India's Dehydration Dilemma: Can a Corporate Campaign Bridge a Critical Health Gap?

MUMBAI, India – July 30, 2026 – On World ORS Day, as India grapples with the consequences of increasingly prolonged and intense summers, Cipla Health has launched a nationwide campaign aimed at a deceptively simple, yet critical, public health tool: Oral Rehydration Solution (ORS). The initiative, titled 'W.H.O. hai toh woh ORS hai', seeks to cut through market confusion and educate consumers on the importance of choosing formulations recommended by the World Health Organization. While the campaign promotes the company's Prolyte ORS brand, its mission touches upon a far deeper issue—a persistent and dangerous gap between public awareness and effective health practices in a nation where dehydration is a growing threat.

The Anatomy of a Public Health Gap

For decades, ORS has been hailed as a life-saving intervention, particularly for managing diarrheal diseases, a leading cause of mortality in children under five. Yet, adoption remains alarmingly inconsistent. The latest National Family Health Survey (NFHS-5) data reveals that only 62% of children under five suffering from diarrhea received ORS, exposing a significant chasm between a known solution and its real-world application. This isn't a problem of access alone, but of understanding.

Internal data from Cipla Health paints a stark picture of this 'know-do gap'. While prompted awareness of ORS is relatively high at nearly 70%, a staggering 75% of those aware consumers cannot recall what the acronym 'ORS' stands for. More critically, only 61% remember ever seeing the crucial 'W.H.O.-recommended' mark on packaging. This suggests that for many, ORS is a generic term, not a specific, scientifically validated formulation, leaving them vulnerable to choosing less effective, sugary beverages or improperly formulated solutions.

This confusion has tangible consequences. In on-ground activations conducted by the company in Hyderabad and Mumbai, the need for better education was clear. In Mumbai, 31% of patients engaged in counseling sessions were unaware of the factors to consider when purchasing an ORS product. In Hyderabad, while most participants acknowledged that dehydration impacted their productivity, 9% were entirely unaware of the role ORS could play in managing it. These figures highlight a widespread lack of health literacy that public health experts say is a major barrier to improving health outcomes across the country.

The Science of Rehydration: Why 'W.H.O.-Recommended' Matters

The campaign's focus on the W.H.O. standard is not merely a branding exercise; it is rooted in decades of medical science. The effectiveness of ORS hinges on a precise physiological mechanism: sodium-glucose co-transport. Even during severe diarrhea, the small intestine can absorb water effectively when it is delivered with a specific, balanced concentration of glucose and essential salts like sodium and potassium. This is what distinguishes a W.H.O.-formulated ORS from sports drinks or fruit juices, which often contain excessive sugar that can worsen dehydration.

The W.H.O. itself has refined this technology. In 2002, it recommended a shift to a 'reduced-osmolarity' ORS (245 mOsm/L), an improvement on the original 1979 formula. This updated version was proven to be even more effective, reducing stool output and the duration of diarrhea without adverse effects. Its inclusion on the W.H.O.'s Essential Medicines List underscores its status as a non-negotiable tool in global public health, credited with preventing up to 93% of diarrhea-related deaths worldwide. Cipla Health's campaign aims to translate this scientific consensus into a simple, actionable checkpoint for consumers at the pharmacy counter.

“As India experiences longer summers, rising temperatures, and a growing burden of heat-related illnesses, dehydration is becoming an increasingly critical public health challenge,” said Shivam Puri, CEO of One India Business at Cipla. “As category leaders, we have a responsibility that goes beyond providing solutions; we must empower people with the knowledge to make informed decisions.”

Industry's Role in Bridging the Divide

Cipla Health's initiative represents a significant investment in public health education, positioning a corporate entity as a key player in addressing a national health literacy deficit. The campaign's strategy is multi-pronged, extending beyond traditional advertising to include hospital-led awareness programs with partners like MGM Group of Hospitals, educational content from nutritionists and fitness creators, and direct outreach to healthcare professionals.

This educational push comes as the Indian ORS market, estimated at around Rs 1000 crore, becomes increasingly competitive. While FDC Limited's Electral dominates with over 50% market share, Cipla Health's Prolyte ORS has seen its own share grow to over 14%, particularly in the ready-to-drink tetra pack segment. The entry of FMCG giants like Reliance and Hindustan Unilever is set to intensify this competition further. In this crowded field, a campaign focused on scientific validation and consumer empowerment could serve as a powerful market differentiator.

By anchoring its messaging in W.H.O. guidelines, the company is attempting to elevate the conversation from brand preference to medical efficacy. It's a strategy that could not only bolster its own market position but also raise the standard for the entire category, pushing competitors to clarify their own formulations and forcing consumers to become more discerning.

Navigating a Market of Misinformation

The challenge Cipla Health faces is emblematic of a broader struggle in India's healthcare landscape. With the proliferation of health information—and misinformation—online, consumers are often left to navigate a confusing mix of marketing claims, social media trends, and anecdotal advice. Public health specialists warn that low health literacy makes it difficult for many to distinguish credible, evidence-based guidance from unsubstantiated claims.

“We commonly see that many people do not recognise the early signs of dehydration or understand the role ORS can play in managing it,” noted Dr. Usha Chennuru, Senior Director of Medical Services at Cipla Health. “Greater awareness and timely action can help people make more informed choices.”

Ultimately, the success of this campaign and others like it will depend on their ability to do more than just build brand recognition. The true measure of impact lies in fundamentally shifting consumer behavior from passive acceptance to active, informed decision-making. In a market saturated with choices and noise, empowering consumers to understand the science behind the label may be the most critical intervention of all.